IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection-Reference-Cited by-同舟云学术

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection

Published:2013-12-04 Issue:1 Volume:16 Page:81-91
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Beiko Jason,Suki Dima,Hess Kenneth R.,Fox Benjamin D.,Cheung Vincent,Cabral Matthew,Shonka Nicole,Gilbert Mark R.,Sawaya Raymond,Prabhu Sujit S.,Weinberg Jeffrey,Lang Frederick F.,Aldape Kenneth D.,Sulman Erik P.,Rao Ganesh,McCutcheon Ian E.,Cahill Daniel P.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/16/1/81/16857908/not159.pdf

Reference46 articles.

1. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol,2007

2. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas;Glantz;Neurology,1991

3. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas;Nobusawa;Clin Cancer Res,2009

4. Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading;Prayson;J Neurol Sci,2000

5. Mutations in CIC and FUBP1 contribute to human oligodendroglioma;Bettegowda;Science,2011

Cited by 371 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group;The Lancet Oncology;2024-09

2. The Impact of Tu Resection on Survival and Functional Outcomes for Patients with Primary Central Nervous System Lymphoma;Clinical Neurology and Neurosurgery;2024-09

3. Deep Learning for MRI Segmentation and Molecular Subtyping in Glioblastoma: Critical Aspects from an Emerging Field;Biomedicines;2024-08-16

4. Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign;Journal of Neuro-Oncology;2024-08-12

5. Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models;Cancers;2024-07-24